The importance of GLP-1 and PYY in resistant starch's effect on body fat in mice

Molecular Nutrition and Food Research

Volumn 59, Issue 5, 2015, Pages 1000-1003

  Zhou, June ^a,b   Martin, Roy J ^a,c   Raggio, Anne M ^a,c   Shen, Li ^a,c   McCutcheon, Kathleen ^c   Keenan, Michael J ^a,c  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY AGRICULTURAL CENTER   (United States)

Author keywords

Antagonist; Dietary Fiber; GLP 1 receptor; Obesity; PYY receptor

Indexed keywords

MUS; RODENTIA;

GLUCAGON LIKE PEPTIDE 1; PEPTIDE YY; STARCH;

ADIPOSE TISSUE; ANIMAL; BLOOD; DIETARY FIBER; METABOLISM; MOUSE; PHARMACOLOGY; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; DIETARY FIBER; GLUCAGON-LIKE PEPTIDE 1; MICE; PEPTIDE YY; STARCH;

EID: 84928760312     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400904     Document Type: Article

References (24)

1. Higgins, J. A., Brown, I. L., Resistant starch: a promising dietary agent for the prevention/treatment of inflammatory bowel disease and bowel cancer. Curr. Opin. Gastroenterol. 2013, 29, 190-194.
2. Higgins, J. A., Resistant starch and energy balance: impact on weight loss and maintenance. Crit. Rev. Food Sci. Nutr. 2014, 54, 1158-1166.
3. Hullar, M. A., Burnett-Hartman, A. N., Lampe, J. W., Gut microbes, diet, and cancer. Cancer Treat. Res. 2014, 159, 377-399.
4. Asp, N. G., Resistant starch-an update on its physiological effects. Adv. Exp. Med. Biol. 1997, 427, 201-210.
5. Bird, A. R., Conlon, M. A., Christophersen, C. T., Topping, D. L., Resistant starch, large bowel fermentation and a broader perspective of prebiotics and probiotics. Benef. Microbes 2011, 1, 423-431.
6. Brennan, C. S., Dietary fibre, glycaemic response, and diabetes. Mol. Nutr. Food Res. 2005, 49, 560-570.
7. Jenkins, D. J., Kendall, C. W., Resistant starches. Curr. Opin. Gastroenterol. 2000, 16, 178-183.
8. Garcia, T. A., McCutcheon, K. L., Francis, A. R., Keenan, M. J. et al., The effects of resistant starch on gastrointestinal organs and fecal output in rats. FASEB J. 2003, 17, A335.
9. Al-Tamimi, E. K., Seib, P. A., Snyder, B. S., Haub, M. D., Consumption of cross-linked resistant starch (RS4(XL)) on glucose and insulin responses in humans. J. Nutr. Metab. 2010, 2010, doi: 10.1155/2010/651063.
10. Keenan, M. J., Janes, M., Robert, J., Martin, R. J. et al., Resistant starch from high amylose maize (HAM-RS2) reduces body fat and increases gut bacteria in ovariectomized (OVX) rats. Obesity (Silver Spring) 2013, 21, 981-984.
11. Keenan, M. J., Zhou, J., McCutcheon, K. L., Raggio, A. M. et al., Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity 2006, 14, 1523-1534.
12. Vidrine, K., Ye, J., Martin, R. J., McCutcheon, K. L. et al., Resistant starch from high amylose maize (HAM-RS2) and Dietary butyrate reduce abdominal fat by a different apparent mechanism. Obesity 2013, 22, 344-348.
13. Zhou, J., Keenan, M. J., Fernandez-Kim, S. O., Pistell, P. J. et al., Dietary resistant starch improves selected brain and behavioral functions in adult and aged rodents. Mol. Nutr. Food Res. 2013, 57, 2071-2074.
14. Keenan, M. J., Martin, R. J., Raggio, A. M., McCutcheon, K. L. et al., High-amylose resistant starch increases hormones and improves structure and function of the gastrointestinal tract: a microarray study. J. Nutrigenet. Nutrigenomics 2012, 5, 26-44.
15. Shen, L., Keenan, M. J., Martin, R. J., Tulley, R. T. et al., Dietary resistant starch increases hypothalamic POMC expression in rats. Obesity 2009, 17, 40-45.
16. Shen, L., Keenan, M. J., Raggio, A., Williams, C. et al., Dietary-resistant starch improves maternal glycemic control in Goto-Kakizaki rat. Mol. Nutr. Food Res. 2011, 55, 1499-1508.
17. Zhou, J., Martin, R. J., Tulley, R. T., Raggio, A. M. et al., Failure to ferment dietary resistant starch in specific mouse models of obesity results in no body fat loss. J. Agric. Food Chem. 2009, 57, 8844-8851.
18. Zhou, J., Martin, R. J., Tulley, R. T., Raggio, A. M. et al., Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am. J. Physiol. Endocrinol. Metab. 2008, 295, E1160-E1166.
19. Zhou, J., Hegsted, M., McCutcheon, K. L., Keenan, M. J. et al., Peptide YY and proglucagon mRNA expression patterns and regulation in the gut. Obesity 2006, 14, 683-689.
20. Brothers, S. P., Saldanha, S. A., Spicer, T. P., Cameron, M. et al., Selective and brain penetrant neuropeptide y y2 receptor antagonists discovered by whole-cell high-throughput screening. Mol. Pharmacol. 2010, 77, 46-57.
21. Abbott, C. R., Small, C. J., Kennedy, A. R., Neary, N. M. et al., Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res. 2005, 1043, 139-144.
22. Neary, N. M., Small, C. J., Druce, M. R., Park, A. J. et al., Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology 2005, 146, 5120-5127.
23. Talsania, T., Anini, Y., Siu, S., Drucker, D. J. et al., Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 2005, 146, 3748-3756.
24. Parker, J. A., McCullough, K. A., Field, B. C., Minnion, J. S. et al., Glucagon and GLP-1 inhibit food intake and increase c-fos expression in similar appetite regulating centres in the brainstem and amygdala. Int. J. Obes. 2013, 37, 1391-1398.